Kai Schulze

Publications

• Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection Against Influenza H5N1 in Mice
  Frontiers in Immunology. 2017  |   Pubmed ID: 29033942
• Self-replicating RNA Vaccine Functionality Modulated by Fine-tuning of Polyplex Delivery Vehicle Structure
  Journal of Controlled Release : Official Journal of the Controlled Release Society. Nov, 2017  |   Pubmed ID: 28935594
• Bivalent Mucosal Peptide Vaccines Administered Using the LCP Carrier System Stimulate Protective Immune Responses Against Streptococcus Pyogenes Infection
  Nanomedicine : Nanotechnology, Biology, and Medicine. Nov, 2017  |   Pubmed ID: 28887213
• Type I IFN and Not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation Pathway
  EBioMedicine. Aug, 2017  |   Pubmed ID: 28754303
• Role of Autophagy in HIV-1 Matrix Protein P17-Driven Lymphangiogenesis
  Journal of Virology. 08, 2017  |   Pubmed ID: 28592537
• Immunization with Tc52 or Its Amino Terminal Domain Adjuvanted with C-di-AMP Induces Th17+Th1 Specific Immune Responses and Confers Protection Against Trypanosoma Cruzi
  PLoS Neglected Tropical Diseases. Feb, 2017  |   Pubmed ID: 28234897
• New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy
  Current Topics in Microbiology and Immunology. 2016  |   Pubmed ID: 27370343
• Generation of HLA-universal IPSCs-derived Megakaryocytes and Platelets for Survival Under Refractoriness Conditions
  Molecular Medicine (Cambridge, Mass.). May, 2016  |   Pubmed ID: 27262025
• Modeling Influenza Virus Infection: A Roadmap for Influenza Research
  Viruses. Oct, 2015  |   Pubmed ID: 26473911
• Rodents As Pre-clinical Models for Predicting Vaccine Performance in Humans
  Expert Review of Vaccines. 2015  |   Pubmed ID: 26268433
• Inverse Micellar Sugar Glass (IMSG) Nanoparticles for Transfollicular Vaccination
  Journal of Controlled Release : Official Journal of the Controlled Release Society. May, 2015  |   Pubmed ID: 25795506
• Efficient Nanoparticle-mediated Needle-free Transcutaneous Vaccination Via Hair Follicles Requires Adjuvantation
  Nanomedicine : Nanotechnology, Biology, and Medicine. Jan, 2015  |   Pubmed ID: 25200611
• Intranasal Delivery of Influenza RNP Adjuvanted with C-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection Against Virus Challenge
  PloS One. 2014  |   Pubmed ID: 25140692
• Vaccine Adjuvants: Key Tools for Innovative Vaccine Design
  Current Topics in Medicinal Chemistry. 2013  |   Pubmed ID: 24066891
• Development and Characterization of Attenuated Metabolic Mutants of Bordetella Bronchiseptica for Applications in Vaccinology
  Environmental Microbiology. Jan, 2013  |   Pubmed ID: 22676396
• Bis-(3',5')-cyclic Dimeric Adenosine Monophosphate: Strong Th1/Th2/Th17 Promoting Mucosal Adjuvant
  Vaccine. Jul, 2011  |   Pubmed ID: 21619907
• The FAI Protein of Group C Streptococci Acts As a Mucosal Adjuvant by the Specific Targeting and Activation of B Cells
  International Journal of Medical Microbiology : IJMM. Jan, 2008  |   Pubmed ID: 17884726
• A Pegylated Derivative of Alpha-galactosylceramide Exhibits Improved Biological Properties
  Journal of Immunology (Baltimore, Md. : 1950). Aug, 2007  |   Pubmed ID: 17675464
• The Bacterial Second Messenger CdiGMP Exhibits Promising Activity As a Mucosal Adjuvant
  Clinical and Vaccine Immunology : CVI. Aug, 2007  |   Pubmed ID: 17567766
• The Bacterial Second Messenger Cyclic DiGMP Exhibits Potent Adjuvant Properties
  Vaccine. Feb, 2007  |   Pubmed ID: 17187906